NorthCrest Asset Manangement’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
+5,261
| New | +$201K | 0.01% | 606 |
|
|
2025
Q1 | – | Sell |
-7,392
| Closed | -$250K | – | 603 |
|
|
2024
Q4 | $250K | Sell |
7,392
-376,196
| -98% | -$12.7M | 0.01% | 514 |
|
|
2024
Q3 | $15.7M | Buy |
383,588
+1,491
| +0.4% | +$61K | 0.47% | 68 |
|
|
2024
Q2 | $14.7M | Buy |
382,097
+3,665
| +1% | +$141K | 0.49% | 63 |
|
|
2024
Q1 | $16.2M | Buy |
378,432
+8,879
| +2% | +$381K | 0.55% | 59 |
|
|
2023
Q4 | $13.7M | Sell |
369,553
-6,340
| -2% | -$235K | 0.52% | 64 |
|
|
2023
Q3 | $13.6M | Buy |
375,893
+8,389
| +2% | +$304K | 0.56% | 60 |
|
|
2023
Q2 | $13.1M | Buy |
367,504
+2,015
| +0.6% | +$71.8K | 0.52% | 64 |
|
|
2023
Q1 | $13M | Buy |
365,489
+40,973
| +13% | +$1.46M | 0.54% | 65 |
|
|
2022
Q4 | $11.4M | Buy |
324,516
+24,744
| +8% | +$869K | 0.65% | 53 |
|
|
2022
Q3 | $8.82M | Buy |
299,772
+1,240
| +0.4% | +$36.5K | 0.48% | 76 |
|
|
2022
Q2 | $16.2M | Buy |
298,532
+11,236
| +4% | +$611K | 0.83% | 33 |
|
|
2022
Q1 | $15.6M | Buy |
+287,296
| New | +$15.6M | 0.74% | 49 |
|